Dupilumab Reduced Severe Exacerbation Rates and Improved Pre-bronchodilator Fev1 in Patients With Moderate-to-Severe Asthma Regardless of Exacerbation History of 蠅1, 蠅2, or 蠅3 Prior Exacerbations: Liberty Asthma Traverse

التفاصيل البيبلوغرافية
العنوان: Dupilumab Reduced Severe Exacerbation Rates and Improved Pre-bronchodilator Fev1 in Patients With Moderate-to-Severe Asthma Regardless of Exacerbation History of 蠅1, 蠅2, or 蠅3 Prior Exacerbations: Liberty Asthma Traverse
المؤلفون: J.F. Maspero, J. Corren, C. Katelaris, M. Castro, M.J.C. Humbert, D.M.G. Halpin, A. Altincatal, N. Pandit-Abid, X. Soler, A. Radwan, J.A. Jacob-Nara, Y.M. Deniz, P.J. Rowe
المصدر: C31. BIOLOGICS WANT TO RULE THE (ASTHMA) WORLD.
بيانات النشر: American Thoracic Society, 2023.
سنة النشر: 2023
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::cfdf63fb0695e2495051558b39f062aeTest
https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4742Test
رقم الانضمام: edsair.doi...........cfdf63fb0695e2495051558b39f062ae
قاعدة البيانات: OpenAIRE